Table 1.
Characteristics of the study population
| Number | 40 |
| Age, years | 71 ± 13 |
| Male gender, number (percentage) | 21 (53) |
| Body mass index, kg/m2 | 28 ± 7 |
| Premorbidities, number (percentage) | |
| Chronic arterial hypertension | 23 (58) |
| Obstructive coronary artery disease | 10 (25) |
| Compensated congestive heart failure | 12 (30) |
| Chronic obstructive pulmonary disease | 8 (20) |
| Chronic renal insufficiency | 14 (35) |
| Chronic liver disease | 4 (10) |
| Neoplasm | 3 (8) |
| Chronic beta-blocker therapy, number (percentage) | 15 (38) |
| Source of infection, number (percentage) | |
| Liver/Abdomen | 21 (53) |
| Lung | 10 (25) |
| Skin/Soft tissue | 3 (8) |
| Joint/Bone | 2 (5) |
| Catheter/Device | 1 (3) |
| Urogenital tract | 1 (3) |
| Unknown origin | 2 (5) |
| Continuous veno-venous hemofiltration, number (percentage) | 28 (70) |
| Multiple organ dysfunction syndrome score (12), points | 9.9 ± 2.3 |
| Simplified Acute Physiology Score II, points | 53 ± 16 |
| Intensive care unit length of stay, days | 15 ± 11 |
| 28-day mortality, number (percentage) | 13 (33) |
Data are presented as mean value ± standard deviation, if not indicated otherwise.